Call for Abstracts

The Late Breaking abstract submission is now open until August 30.


If you have current research or case studies and you missed the regular submission session, this is your last chance to present your results at the EACS 2017 Conference.
If you are already registered for the Conference or are joining us for the first time, please click here to submit your abstract and register.


All abstracts accepted for the conference will be presented as oral or poster presentations. They will be published on the abstract USB stick (available on site).


As an affiliated event of the 16th European AIDS Conference, you are invited to co-submit your abstract to the 19th International Workshop on Co-morbidities and Adverse Drug Reactions in HIV

Instructions to Authors

Carefully read the guidelines below before submitting your abstract. Acknowledgement of the receipt of your submission will be sent to the corresponding author’s e-mail address immediately upon submission. If you do not receive the confirmation e-mail, please do not submit the abstract again, instead please contact the Conference Secretariat at for advice.

Invited speakers are not required to submit abstracts for the lectures they are invited to.


Submission Guidelines

  • Abstracts must be submitted in English only.
  • The text should not exceed 300 words (excluding abstract title & authors).
  • Abstracts sent by fax, post or e-mail will not be accepted.
  • Tables and graphics can be included in the abstract. These will not add to the word count.
  • Straight encore submissions without new data will not be accepted. Encores with additional new data will be considered.
  • The text of the abstract should briefly state:
    • Objectives (Indicate the purpose of the study or the hypothesis that was tested);
    • Methods (Include the setting for the study, the subjects, the diagnosis or intervention and the type of statistical analysis; if references are needed, they should be given in the text);
    • Results (Present as clearly as possible the outcome of the study and statistical significance if appropriate);
    • Conclusion (Briefly discuss the data and emphasize the significance of the results).


As long as the abstract has not been submitted, it remains in "Draft" status, which means modifications can be made until the abstract submission deadline. A confirmation of receipt will be sent via e-mail upon submission of an abstract.

Presenting authors should register upon submitting their abstract. Registration must be completed at the latest upon confirmation that the abstract has been accepted as an oral or poster presentation.


Abstract Categories

A. Basic and Translational Science



Pathogenesis and Immunopathogenesis

Human Genomics

Vaccines and Immune Based Therapies

HIV Drug Resistance

Antiretroviral Therapy Preclinical


B1. Clinical Science – Antiretroviral therapy

Antiretroviral Randomized Clinical Trials

Antiretroviral Observational Studies

Pharmacology, Pharmacogenomics and Drug Interactions


B2. Clinical Science – Co-morbidities

Co-morbidities, Ageing


Tuberculosis and Opportunistic Infections

HIV-Associated and non HIV-Associated Tumours

Other Coinfections/Sexually Transmitted Infections


B3. Clinical Science – Hepatitis

Viral Hepatitis



B4. Clinical Science – Women, Pregnancy, and Children

Mother-to-Child Transmission

Gender Issues

Paediatric, Adolescent


C1. Epidemiology

Morbidity/Mortality in the Era of cART

Prevention of Horizontal Transmission, cART as Prevention

Prevalence, Incidence and Dynamics of HIV Epidemics


C2. Social Sciences

Treatment in Resource-Constrained Settings

Social and Behavioural Science

Access to and Models of Care

HIV and Marginalised Groups


Should you have any questions, please contact:

EACS Conference Secretariat

c/o K.I.T. Group GmbH

Association & Conference Management

Kurfürstendamm 71

10709 Berlin – Germany

Phone: +49 30 24603-249

Fax: +49 30 24603-269



Registration is open

Second Announcement

Take a look

Call for abstracts

Submissions are closed